A new series of pyrazolidine derivatives was synthesized and evaluated for their ability to inhibit dipeptidyl peptidase IV (DP-IV). Compound 9i was the most active in this series, exhibited IC50 value of 1.56 microM and ED50 value of 80 mg/kg (in vivo DP-IV inhibition; po).
合成了一系列新的
吡唑烷衍
生物,并评估了它们抑制
二肽基肽酶IV(DP-IV)的能力。化合物9i是该系列中活性最高的化合物,IC50值为1.56 microM,ED50值为80 mg / kg(体内DP-IV抑制;口服)。